Publications by authors named "James R Perry"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,509

Total Likes

603

Extended Reach

8,000,823

Social Features

213
L
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results.
Zev A Wainberg, Colin D Weekes, Muhammad Furqan, Pashtoon M Kasi, Craig E Devoe, James R Perry

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A population-based analysis of the molecular landscape of glioma in adolescents and young adults reveals insights into gliomagenesis.
Julie Bennett, Adrian B Levine, Liana Nobre, Logine Negm, Jiil Chung, James R Perry

Nat Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Expert Consensus Recommendations for the Diagnosis and Management of Glioblastoma: Results of a Delphi Study.
Warren P Mason, Rebecca A Harrison, Sarah Lapointe, Mary Jane Lim-Fat, Mary V MacNeil, James R Perry

Curr Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trial.
Annika Malmström, Felix B Oppong, Christopher J O Callaghan, Wolfgang Wick, Normand Laperriere, James R Perry

Neurooncol Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No benefit from TMZ treatment in glioblastoma with truly unmethylated MGMT promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly glioblastoma patients.
Monika E Hegi, Felix B Oppong, James R Perry, Wolfgang Wick, Roger Henriksson

Neuro Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A longer and/or better life for the oldest old with glioblastoma.
Katrina Roberto, James R Perry

Neurooncol Pract· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial.
Shubham Pant, Zev A Wainberg, Colin D Weekes, Muhammad Furqan, Pashtoon M Kasi, James R Perry

Nat Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dependent efficacy of bevacizumab in recurrent glioblastoma.
Jawad M Melhem, Ali Tahir, Eirena Calabrese, Inga Granovskaya, Eshetu G Atenafu, James R Perry

J Neurooncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates in IDH-Wildtype Glioblastoma.
Jawad M Melhem, Jay Detsky, Mary Jane Lim-Fat, James R Perry

Neurotherapeutics· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the management of elderly patients with glioblastoma: a narrative review.
Sarah A Ironside, Arjun Sahgal, Jay Detsky, Sunit Das, James R Perry

Ann Palliat Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients.
Seth A Climans, Alba A Brandes, J Gregory Cairncross, Keyue Ding, Michael Fay, James R Perry

J Neurooncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary: Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Sunit Das, Arjun Sahgal, James R Perry

Front Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Procarbazine, CCNU and vincristine (PCV) versus temozolomide chemotherapy for patients with low-grade glioma: a systematic review.
Karim Hafazalla, Arjun Sahgal, Blessing Jaja, James R Perry, Sunit Das

Oncotarget· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalizations in elderly glioblastoma patients.
Claire Moroney, James R Perry, Derek S Tsang, Denise Bilodeau, Chris Mueller

Ann Palliat Med· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Therapies for Newly Diagnosed Elderly Patients with Glioblastoma.
Sarah Ironside, Sunit Das, Arjun Sahgal, Claire Moroney, Todd Mainprize, James R Perry

Curr Treat Options Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.
Deborah T Blumenthal, Thierry Gorlia, Mark R Gilbert, Michelle M Kim, L Burt Nabors, James R Perry

Neuro Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation plus Temozolomide in Patients with Glioblastoma.
James R Perry, Normand Laperriere, Warren P Mason

N Engl J Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.
James R Perry, Normand Laperriere, Christopher J O'Callaghan, Alba A Brandes, Johan Menten

N Engl J Med· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular complications in glioma patients.
Emilie Le Rhun, James R Perry

Handb Clin Neurol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to F. Felix et al and M.F. Fay et al.
Caroline Happold, Thierry Gorlia, Oliver Chinot, Mark R Gilbert, L Burt Nabors, James R Perry

J Clin Oncol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioblastoma in the elderly: making sense of the evidence.
Matthew Mason, Normand Laperriere, Wolfgang Wick, David A Reardon, Annika Malmstrom, James R Perry

Neurooncol Pract· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.
Caroline Happold, Thierry Gorlia, Olivier Chinot, Mark R Gilbert, L Burt Nabors, James R Perry

J Clin Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys.
Dan H Barouch, Galit Alter, Thomas Broge, Caitlyn Linde, Margaret E Ackerman, James R Perry

Science· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study.
L Burt Nabors, Karen L Fink, Tom Mikkelsen, Danica Grujicic, Rafal Tarnawski, James R Perry

Neuro Oncol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis